|
| |
| | | 52228 | | 15.04.1994 | | GE Healthcare AG | | 22.12.2004 | | | | | | | | | | | 14.01.14. | | | | 14.01. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Visipaque 150 mg/mL | Injektionslösung | Solution injectable () | V08AB09 | | | 02 | Visipaque 270 mg/mL | Injektionslösung | Solution injectable (Iodixanol 550 mg/ml) | V08AB09 | | | 03 | Visipaque 320 mg/mL | Injektionslösung | Solution injectable (Iodixanol 652 mg/ml) | V08AB09 | |
|
|
|
